Health ❯ Healthcare ❯ Patient Care ❯ Treatment Options

Oral Medications

Mezigdomide Triplet Cuts Risk of Myeloma Progression by 52% in Phase 3 Trial

The SUCCESSOR-2 results offer a potent oral treatment option that markedly lengthened progression-free survival while raising safety and approval questions.

27 ARTICLES

last mo.

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

10 ARTICLES

3mo ago

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

3 ARTICLES

4mo ago

FDA Approves First All-Oral, Fixed-Duration First-Line CLL/SLL Regimen: Calquence Plus Venetoclax

14 ARTICLES

5mo ago

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

38 ARTICLES

6mo ago

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

8 ARTICLES

6mo ago

FDA Clears First New Oral Gonorrhea Antibiotics in Over 30 Years

3 ARTICLES

9mo ago

FDA Clears Novartis' Rhapsido, First Oral BTK Inhibitor for Chronic Hives

44 ARTICLES

9mo ago

Oral GLP-1 Pill Orforglipron Delivers Phase III Weight Loss as Obesity Care Broadens Beyond Injections

32 ARTICLES

10mo ago

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings

9 ARTICLES

10mo ago

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

7 ARTICLES

10mo ago

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer

12 ARTICLES

last yr.

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury